Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2023-03-14 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the opening position and dealings in relevant securities by a person with interests of 1% or more in a company involved in a takeover (Horizon Therapeutics PLC). This type of disclosure is a specific regulatory requirement for transparency during M&A activity, and since it does not fit into the 'M&A Activity' (TAR) category (which is for company-level announcements) or 'Major Shareholding Notification' (MRQ) (which is for threshold crossings), it is classified as a Regulatory Filing (RNS).
2023-03-14 English
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests and dealings in relevant securities by a person (Citadel Group) holding 1% or more of an offeror/offeree (Horizon Therapeutics PLC). This type of disclosure is a specific regulatory requirement related to M&A activity, but since it is a standardized disclosure form rather than a general M&A announcement, it falls under the category of Regulatory Filings (RNS) as it is a mandatory disclosure submitted to a Regulatory Information Service.
2023-03-13 English
Form 8.3 - HORIZON THERAPEUTICS PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the interests and short positions of a major shareholder (Citadel Group) in the securities of an offeror/offeree (Horizon Therapeutics PLC). This type of filing is a mandatory regulatory disclosure regarding significant shareholding and dealing activity during a takeover process, which falls under the 'Major Shareholding Notification' category.
2023-03-10 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure under the Irish Takeover Panel Act, which is a standard regulatory filing used to report interests and dealings in relevant securities by persons with 1% or more interest during a takeover offer. This specific form is a 'Major Shareholding Notification' (MRQ) as it details the discloser's (Citadel Group) position and transactions in the securities of the offeror/offeree (Horizon Therapeutics PLC).
2023-03-09 English
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the interests, short positions, and dealings in relevant securities of an offeror/offeree (Horizon Therapeutics PLC) by a disclosing party (Citadel Group). This type of disclosure is a specific regulatory requirement for transparency during takeover activities and does not fit into categories like M&A announcements (which are usually corporate-led) or director dealings. Therefore, it is classified as a Regulatory Filing (RNS).
2023-03-08 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Horizon Therapeutics PLC). This type of disclosure is a specific regulatory requirement for M&A activity and shareholding transparency, fitting best under the 'Regulatory Filings' (RNS) category as it is a formal regulatory announcement submitted via a Regulatory Information Service.
2023-03-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.